OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:OraSure Technologies Inc (OSUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010884
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

OraSure Technologies Inc (OSUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OraSure Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OraSure Technologies Inc, Medical Equipment, Deal Details 10
Partnerships 10
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
DNA Genotek Enters Into Distribution Agreement With Abyntek Biopharma 11
Equity Offering 12
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 12
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 13
Acquisition 14
OraSure Technologies Completes Acquisition Of DNA Genotek 14
OraSure Technologies Inc – Key Competitors 16
OraSure Technologies Inc – Key Employees 17
OraSure Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 01, 2017: OraSure Announces 2017 Third Quarter Financial Results 19
Aug 02, 2017: OraSure Announces 2017 Second Quarter Financial Results 21
May 03, 2017: OraSure Announces 2017 First Quarter Financial Results 23
Feb 08, 2017: OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results 25
Nov 02, 2016: OraSure Announces 2016 Third Quarter Financial Results 27
Aug 03, 2016: OraSure Announces 2016 Second Quarter Financial Results 29
May 04, 2016: OraSure Announces 2016 First Quarter Financial Results 31
Feb 03, 2016: OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015 32
Corporate Communications 34
Jun 22, 2017: OraSure Technologies Appoints Mara G. Aspinall to Board of Directors 34
Feb 24, 2017: OraSure Technologies Announces Director Retirement 35
Nov 15, 2016: OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors 36
Apr 15, 2016: OraSure Technologies Appoints New Chief Science Officer 37
Mar 23, 2016: OraSure Technologies Appoints Eamonn P. Hobbs to its Board of Directors 38
Legal and Regulatory 39
Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 39
Other Significant Developments 40
Nov 29, 2016: OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program 40
Aug 23, 2016: HHS awards $7 Million to OraSure to Speed Development of Zika Diagnostic Test 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
OraSure Technologies Inc, Medical Equipment, Key Facts, 2016 2
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OraSure Technologies Inc, Deals By Market, 2011 to YTD 2017 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
DNA Genotek Enters Into Distribution Agreement With Abyntek Biopharma 11
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 12
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 13
OraSure Technologies Completes Acquisition Of DNA Genotek 14
OraSure Technologies Inc, Key Competitors 16
OraSure Technologies Inc, Key Employees 17
OraSure Technologies Inc, Other Locations 18
OraSure Technologies Inc, Subsidiaries 18

★海外企業調査レポート[OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reach PLC:企業の戦略・SWOT・財務分析
    Reach PLC - Strategy, SWOT and Corporate Finance Report Summary Reach PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Oncor Electric Delivery Company LLC:電力:M&Aディール及び事業提携情報
    Summary Oncor Electric Delivery Company LLC (Oncor) a subsidiary of NextEra Energy, Inc., is a regulated electricity transmission and distribution company that operates distribution and transmission systems. It provides transmission grid connections to merchant generation facilities and interconnect …
  • Kohler Co:企業の戦略的SWOT分析
    Kohler Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Westminster Travel Limited:企業の戦略・SWOT・財務分析
    Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report Summary Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Genalyte Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genalyte Inc (Genalyte) is a lab testing service provider. The company’s services include data analysis, phlebotomist for blood draw, integration with existing emr, phlebotomist for blood draw, applications for test order and results review and clinical lab scientist. It provides instruments …
  • Aquinox Pharmaceuticals Inc (AQXP)-製薬・医療分野:企業M&A・提携分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a clinical-stage pharmaceutical company which develops targeted therapeutics in the areas of inflammation and immuno-oncology. The company's lead product candidate AQX-1125, is a SHIP1 activator which is a natural modulator of the PI3K pathway to redu …
  • Intra Energy Corporation Ltd (IEC):企業の財務・戦略的SWOT分析
    Intra Energy Corporation Ltd (IEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Punjab & Sind Bank:企業の戦略・SWOT・財務情報
    Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report Summary Punjab & Sind Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Epigenomics AG (ECX)-医療機器分野:企業M&A・提携分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Spark Capital:企業のM&A・事業提携・投資動向
    Spark Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Spark Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Bureau Veritas SA:企業の戦略・SWOT・財務分析
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DiaCarta Inc-医療機器分野:企業M&A・提携分析
    Summary DiaCarta Inc (DiaCarta) develops and commercializes molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation de …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Centrexion Therapeutics Corp (CNTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • MAN Diesel & Turbo SE-エネルギー分野:企業M&A・提携分析
    Summary MAN Diesel & Turbo SE (MAN Diesel), a subsidiary of MAN SE, is a large-bore diesel engines and turbomachinery provider. Its product portfolio includes turbochargers, propellers, gas engines and chemical reactors; and goods include marine propulsion systems, turbomachinery units for oil and g …
  • Arkray Inc:企業の製品パイプライン分析2018
    Summary Arkray Inc (Arkray), formerly KDK Corp is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis applications. Its products comprise automatic glycohemoglobin analyzer for diabetes, automated analy …
  • Tommy Hilfiger Licensing LLC:企業の戦略・SWOT・財務情報
    Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report Summary Tommy Hilfiger Licensing LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆